Our Research, Medical and Innovation Department works to improve the UK environment for the research, development and manufacturing of medicines. The focus is also on promoting industry-academic-NHS collaboration and ensuring the UK is a leader in stratified medicines, early stage clinical studies and in the development of data on how medicines provide value to patients and the NHS (Real World Data).
Following her appearance on this week’s The Naked Scientists podcast on 'Drug Discovery', Dr Magda Papadaki, ABPI’s Head of Manufacturing Innovation, writes about realising the potential of cell and gene therapy.Read more
The Times Higher Education World University Rankings have, for the first time, named Oxford and Cambridge as the world’s two top universities. ABPI’s new Head of Education and Academic Liaison, Andrew Croydon, says this latest news adds to the weight of evidence that any Brexit deal should secure the UK’s access to the best science talent and research projects around the world.Read more
Following last night's BBC Panorama episode - 'A Prescription for Murder?' - Dr Sheuli Porkess, ABPI's Head of Medical Affairs and Clinical Research, gives her reaction to the program and its views on SSRI medicines.Read more
Pharmaceutical companies are increasingly working in partnership with other firms, academia, and catapults through collaborative models, in the search to discover and develop new medicines, says a new report out today.Read more
The Government has today announced its commitment to launch the Early Access to Medicines Scheme (EAMS) in April. The journey towards this announcement started back in 2006 when the need to get medicines to patients faster, without compromising safety, was highlighted by Sir David Cooksey¹.Read more